MNOV Medicinova Inc

Price (delayed)

$1.43

Market cap

$70.14M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.17

Enterprise value

$23.22M

MediciNova, Inc. is a publicly-traded biopharmaceutical company founded upon developing novel, small-molecule therapeutics for the treatment of diseases with unmet medical needs with a primary commercial focus on the U.S. ...

Highlights
MNOV's net income is up by 38% YoY
MNOV's EPS is up by 37% year-on-year
The quick ratio has grown by 21% from the previous quarter but it has contracted by 8% YoY
The debt has soared by 53% YoY
The equity has declined by 12% year-on-year and by 4.1% since the previous quarter

Key stats

What are the main financial stats of MNOV
Market
Shares outstanding
49.05M
Market cap
$70.14M
Enterprise value
$23.22M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.17
Price to sales (P/S)
70.14
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
23.22
Earnings
Revenue
$1M
EBIT
-$8.41M
EBITDA
-$8.19M
Free cash flow
-$8.14M
Per share
EPS
-$0.17
Free cash flow per share
-$0.17
Book value per share
$1.22
Revenue per share
$0.02
TBVPS
$1.09
Balance sheet
Total assets
$62.89M
Total liabilities
$3.06M
Debt
$217,887
Equity
$59.83M
Working capital
$45.35M
Liquidity
Debt to equity
0
Current ratio
19.07
Quick ratio
18.78
Net debt/EBITDA
5.73
Margins
EBITDA margin
-819%
Gross margin
100%
Net margin
-840.9%
Operating margin
-962.6%
Efficiency
Return on assets
-12.6%
Return on equity
-13.3%
Return on invested capital
-231.5%
Return on capital employed
-13.9%
Return on sales
-840.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

MNOV stock price

How has the Medicinova stock price performed over time
Intraday
2.88%
1 week
0.7%
1 month
5.93%
1 year
-43.92%
YTD
-4.67%
QTD
-0.69%

Financial performance

How have Medicinova's revenue and profit performed over time
Revenue
$1M
Gross profit
$1M
Operating income
-$9.63M
Net income
-$8.41M
Gross margin
100%
Net margin
-840.9%
MNOV's net income is up by 38% YoY
The operating income is up by 34% year-on-year and by 2.8% since the previous quarter
MNOV's operating margin is up by 2.8% QoQ

Growth

What is Medicinova's growth rate over time

Valuation

What is Medicinova stock price valuation
P/E
N/A
P/B
1.17
P/S
70.14
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
23.22
MNOV's EPS is up by 37% year-on-year
The P/B is 47% lower than the 5-year quarterly average of 2.2 and 16% lower than the last 4 quarters average of 1.4
The equity has declined by 12% year-on-year and by 4.1% since the previous quarter

Efficiency

How efficient is Medicinova business performance
MNOV's ROIC has shrunk by 161% YoY but it is up by 3% QoQ
Medicinova's return on equity has increased by 30% YoY
The ROA rose by 29% YoY

Dividends

What is MNOV's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for MNOV.

Financial health

How did Medicinova financials performed over time
MNOV's current ratio is up by 22% since the previous quarter but it is down by 8% year-on-year
MNOV's total liabilities is down by 21% QoQ and by 10% YoY
The debt is 100% less than the equity
The debt has soared by 53% YoY
The equity has declined by 12% year-on-year and by 4.1% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.